证券代码：688357 证券简称：建龙微纳 公告编号：2025-063 转债代码：118032 转债简称：建龙转债 洛阳建龙微纳新材料股份有限公司 关于注销募集资金专项账户的公告 2024年12月28日，公司披露了《关于以简易程序向特定对象发行股票募投项目结项的公告》（公告编 号：2024-063），对本次募集资金投资项目"吸附材料产业园改扩建项目（一期）"进行结项，并拟在代 付款项全部结清后注销募集资金专户。 本次注销的募集资金专户具体信息如下： ■ 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内 容的真实性、准确性和完整性依法承担法律责任。 洛阳建龙微纳新材料股份有限公司（以下简称"公司"）2022年以简易程序向特定对象非公开发行股票募 集资金按照相关法律法规、规范性文件等的规定在银行开立了募集资金专户。鉴于公司上述募集资金投 资项目"吸附材料产业园改扩建项目（一期）"已结项，募集资金已按规定使用完毕，公司按照相关要求 将对应的募集资金专户予以注销，具体情况如下： 一、募集资金情况 根据中国证券监督管理委员会于2022年2月18日出具的《关于同意洛阳建龙微纳新材 ...

建龙微纳公告称，2022年公司以简易程序向特定对象非公开发行123.50万股股票，募集资金1.94亿元， 扣除发行费用后，实际募资净额1.89亿元。募集资金用于"吸附材料产业园改扩建项目（一期）"。2024 年12月28日，该项目结项。鉴于待付款项已结清，募集资金使用完毕，公司于近日注销中国工商银行偃 师支行、招商银行洛阳分行两个募集资金专户，相关监管协议随之终止。 ...

Core Viewpoint - Beijing Beishuiyuan Technology Co., Ltd. (Beishuiyuan) has announced a financing plan totaling 8 billion yuan to expand its financing channels, reduce costs, and enhance fund management flexibility [1][4]. Financing Plan - The financing plan includes the issuance of medium-term notes not exceeding 4 billion yuan and super short-term financing bonds also not exceeding 4 billion yuan [1][4]. - The funds will be used for project construction, supplementing working capital, and repaying interest-bearing debts [1][4]. Company Overview - Beishuiyuan specializes in environmental protection and water treatment, providing comprehensive technical solutions through the development and manufacturing of advanced membrane materials and related systems [4]. - The company's products are applied in five major areas: wastewater resource utilization, high-quality drinking water, seawater desalination, industrial zero discharge, and salt lake resource utilization [4]. Accounts Receivable Situation - As of September 30, 2025, Beishuiyuan's accounts receivable reached 12.638 billion yuan, showing a slight decrease from 12.4 billion yuan at the end of 2024, but still at a high industry level [5]. - The accounts receivable turnover rate declined from 0.9 in 2022 to 0.73 in 2024, indicating an extended cash recovery cycle [5]. Industry Context - The difficulty in recovering accounts receivable is a common issue in the environmental protection industry, with a total of 156.26 billion yuan in accounts receivable reported across 115 listed environmental companies as of June 30, 2025 [5]. - Beishuiyuan's management is actively working to reduce accounts receivable and contract assets through internal and external strategies [6]. Financial Performance - Beishuiyuan's revenue for 2024 was 8.549 billion yuan, a year-on-year decrease of 4.51%, with a net profit of only 59 million yuan, down 92.34% [6]. - The company reported a net cash flow from operating activities of -238 million yuan in 2024, a significant decline from 331 million yuan in 2023, although there are signs of improvement in 2025 [6]. Financing Strategy - The combination of short-term and medium-term financing strategies is intended to quickly supplement cash flow and optimize debt structure, thereby reducing short-term repayment pressure [6].

Group 1 - The core viewpoint of the article is that Huazhong Securities has given a "buy" rating to Bluestar Technology (300487.SZ) with a latest price of 54.4 yuan, citing strong performance in the adsorption materials business as a key driver for continued growth [1] - The report highlights that the basic warehouse business of adsorption materials is developing steadily, which is driving the company's sustained performance growth [1] - It notes that the performance is under some pressure due to income tax impacts, but the growth trend is expected to continue through Q3 2025 [1]

Investment Rating - The report maintains a "Buy" rating for the company [1][11]. Core Insights - The company has shown resilience in its core business of adsorption materials, achieving a net profit of 652 million yuan for the first three quarters of 2025, a year-on-year increase of 9.27% [7][8]. - The gross profit margin has improved to 55.62% in Q3 2025, reflecting a year-on-year increase of 4.42 percentage points and a quarter-on-quarter increase of 3.96 percentage points [7][8]. - The company plans to invest 1.15 billion yuan in a new high-end materials industrial park to support the growth of its life sciences segment [9][10]. Summary by Sections Financial Performance - For Q3 2025, the company reported revenue of 686 million yuan, a year-on-year increase of 14.86% and a quarter-on-quarter increase of 2.29% [7]. - The net profit for Q3 2025 was 207 million yuan, showing a year-on-year increase of 7.72% but a quarter-on-quarter decrease of 17.58% [7]. - The gross profit margin for the first three quarters of 2025 was 52.81%, up 4.16 percentage points year-on-year [8]. Business Development - The life sciences segment has been a key growth driver, with ongoing investments to meet increasing demand and enhance production capacity [9]. - The company has established long-term contracts with major clients in the high-end drinking water sector, leading to increased market penetration [10]. Profit Forecast - The report projects revenues of 2.765 billion yuan, 3.425 billion yuan, and 4.274 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 932 million yuan, 1.167 billion yuan, and 1.520 billion yuan [11][13].

Core Viewpoint - The steady growth in the demand for chemical catalysts in China is driven by multiple industrial factors, including stable demand in traditional petrochemical sectors and the booming markets and technical requirements of emerging fields like hydrogen fuel cells and biofuels [1][6]. Group 1: Industry Overview - Chemical catalysts are essential materials in the chemical industry, acting as the "core engine" that accelerates reactions and enhances product selectivity while reducing energy consumption and by-product generation [2][4]. - The market for chemical catalysts in China is experiencing rapid growth, with demand expected to rise from 39.5 million tons in 2017 to 49.1 million tons in 2024, and the market size increasing from 26.003 billion yuan to 41.173 billion yuan during the same period [4][6]. Group 2: Production and Demand Trends - The production of chemical catalysts in China is projected to grow from 37.3 million tons in 2017 to 49.9 million tons in 2024, with an expected increase to 52.5 million tons by 2025 [1][6]. - The market size for chemical catalysts is anticipated to reach 42.774 billion yuan by 2025, reflecting a continuous upward trend in both production and demand [1][4]. Group 3: Industry Chain - The upstream of the chemical catalyst industry includes the supply of raw materials and production equipment, while the midstream focuses on the research and production of catalysts, and the downstream applications span various sectors such as petrochemicals, pharmaceuticals, and environmental protection [6][8]. Group 4: Competitive Landscape - The market for chemical catalysts in China is characterized by a diverse supplier landscape, with domestic companies emerging alongside international giants, leading to a competitive yet complementary market environment [8][9]. - Key domestic players include Qilu Huaxin, Zhongchumai, and Kaili New Materials, which are gradually moving towards high-end markets while maintaining a presence in the mid-low end [8][9]. Group 5: Future Trends - The chemical catalyst industry is crucial for advancing green chemistry and improving energy efficiency, with a growing emphasis on developing high-performance and environmentally friendly catalysts [10][11]. - The shift towards low-carbon and green chemical processes is driving the need for innovative catalyst solutions, such as phase transfer catalysts, which are expected to have significant market potential in new industries and technologies [10][11].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% relative to the industry index in the next six months [5][11][19]. Core Viewpoints - The company has achieved breakthroughs in its lithium extraction project in Tibet and is planning to build a high-end materials industrial park for life sciences, which is expected to enhance its growth potential [4][10][11]. - The company's revenue for the first half of 2025 was 1.247 billion yuan, a year-on-year decrease of 3.64%, while the net profit attributable to shareholders increased by 10.01% to 445 million yuan [1][2]. - The growth in the company's performance is primarily driven by its businesses in life sciences, metal resources, water treatment, and ultra-purification, alongside a decrease in raw material costs [2][4]. Financial Summary - The company projects revenues of 3.067 billion yuan, 3.748 billion yuan, and 4.477 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 970 million yuan, 1.222 billion yuan, and 1.516 billion yuan [11][12]. - The company's return on equity (ROE) is expected to remain strong, with figures of 21.1%, 22.1%, and 22.5% for 2025, 2026, and 2027 respectively [11][12]. - The earnings per share (EPS) are projected to be 1.91 yuan, 2.41 yuan, and 2.99 yuan for the years 2025, 2026, and 2027 [11][12]. Business Performance - The company reported a gross margin of 51.26% in the first half of 2025, an increase of 3.78 percentage points year-on-year, indicating improved profitability [2][4]. - The life sciences segment generated revenue of 320 million yuan in the first half of 2025, reflecting a year-on-year growth of 12.43% [10]. - The company has completed and is executing 12 lithium extraction projects, with a combined capacity of nearly 100,000 tons of lithium carbonate/hydroxide [4][9].

Investment Rating - The report maintains a "Buy-B" rating for the company [1] Core Views - The company has shown steady revenue growth and is heavily investing in the life sciences sector, which is expected to benefit from the industrialization of Direct Air Capture (DAC) technology [1][3] - The company's revenue for the first half of 2025 was 1.247 billion yuan, a decrease of 3.64% year-on-year, while the total profit reached 501 million yuan, an increase of 12.35% year-on-year [1] - The gross profit margin improved to 51.26%, up 3.8 percentage points year-on-year, driven by a higher proportion of high-margin products and a decline in raw material prices [2] Financial Performance - The company is projected to achieve revenues of 3.094 billion yuan, 3.844 billion yuan, and 4.703 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 21.15%, 24.24%, and 22.36% [4] - The net profit attributable to the parent company is expected to be 1.011 billion yuan, 1.254 billion yuan, and 1.560 billion yuan for the years 2025, 2026, and 2027, reflecting year-on-year growth rates of 28.40%, 24.05%, and 24.39% [4] - The company’s earnings per share (EPS) are projected to be 1.99 yuan, 2.47 yuan, and 3.07 yuan for the years 2025, 2026, and 2027, with corresponding price-to-earnings (P/E) ratios of 27.62, 22.27, and 17.90 [4] Market Data - As of September 4, 2025, the closing price of the company's stock was 53.48 yuan, with a market capitalization of 27.15 billion yuan [7] - The company’s circulating A-shares account for 3.07 billion out of a total of 5.08 billion shares [7] Strategic Initiatives - The company plans to invest 1.15 billion yuan in a high-end materials industrial park focused on life sciences, which will include various chromatography media and separation materials [2] - The company is expected to benefit from the DAC market, projected to grow from 62 million USD in 2023 to 1.727 billion USD by 2030, with a compound annual growth rate (CAGR) of 60.9% [3]

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6] Core Views - The company achieved a record high profit in the second quarter, with a net profit margin showing significant improvement [2] - The revenue for the first half of 2025 was CNY 12.47 billion, a year-on-year decrease of 3.6%, while the net profit attributable to the parent company was CNY 4.45 billion, an increase of 10.0% [1][3] - The company is expected to see growth in its life sciences, ultra-pure water, and lithium extraction projects, with a forecasted net profit of CNY 10.11 billion, CNY 13.22 billion, and CNY 15.96 billion for 2025-2027 [4] Revenue and Profitability - In Q2 2025, the company reported revenue of CNY 6.71 billion, a year-on-year increase of 1.1% and a quarter-on-quarter increase of 16.3% [1] - The gross margin for Q2 was 51.66%, and the net margin was 37.75%, both showing upward trends [2] - Excluding the impact of the large lithium extraction project, revenue for the first half of 2025 grew by 4.26% [3] Business Segments - The revenue from adsorption materials was CNY 10.07 billion, a year-on-year increase of 3.40%, while system device revenue decreased by 36.53% [3] - The technical service revenue saw a significant increase of 217.55%, primarily due to increased project design income in the lithium extraction sector [3] - Key projects in life sciences and ultra-pure water have made significant progress, with plans for a new high-end materials industrial park in Shaanxi Province [4] Financial Forecasts - The company’s financial projections indicate a steady increase in revenue and net profit over the next few years, with expected revenues of CNY 3.07 billion in 2025 and CNY 5.36 billion in 2027 [5] - The projected net profit for 2025 is CNY 1.01 billion, with a growth rate of 28.48% [5] Market Position - The company operates in the basic chemicals and plastics industry, with a current market capitalization of approximately CNY 26.84 billion [7] - The stock has shown a price range between CNY 37.35 and CNY 68.02 over the past year [7]

Core Viewpoint - Blue Sky Technology has shown a mixed performance in stock price and financial results, with a notable increase in net profit despite a slight decline in revenue [1][2]. Financial Performance - As of June 30, 2025, Blue Sky Technology reported a revenue of 1.247 billion yuan, a year-on-year decrease of 3.64% [2]. - The net profit attributable to shareholders was 445 million yuan, reflecting a year-on-year growth of 10.01% [2]. - Cumulative cash dividends since the A-share listing amount to 1.136 billion yuan, with 866 million yuan distributed over the past three years [3]. Stock Performance - On August 22, 2023, Blue Sky Technology's stock price increased by 2.00%, reaching 53.93 yuan per share, with a total market capitalization of 27.378 billion yuan [1]. - Year-to-date, the stock price has risen by 14.09%, with a 5-day increase of 5.54% and a 60-day increase of 18.89% [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 9.84% to 19,000, while the average circulating shares per person increased by 10.92% to 16,100 shares [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 50.0449 million shares, an increase of 1.0271 million shares from the previous period [3].